Chapter 1 Clinical and Scientific Considerations in Preoperative (Neoadjuvant) Chemotherapy

Chapter 2 Experimental adjuvant chemotherapy: an overview.

Chapter 3 Theoretical Considerations Regarding the Early Use of Adjuvant Chemotherapy

Chapter 5 Implications of Certain Cell Kinetic and Biological Parameters for Preoperative Chemotherapy

Chapter 6 Adjuvant therapy for breast cancer: a brief overview of the NSABP experience and some thoughts on neoadjuvant chemotherapy.

Chapter 7 Factors affecting the development of permanent drug resistance and its impact upon neoadjuvant chemotherapy.

Chapter 8 Impact of Preoperative Chemotherapy for the Surgeon

Chapter 9 Preoperative (neoadjuvant) chemotherapy for breast cancer: outline of the British Columbia Trial.

Chapter 10 Perioperative adjuvant chemotherapy of breast cancer: the Scandinavian experience.

Chapter 11 Perioperative and conventionally timed chemotherapy in operable breast cancer: the Ludwig Breast Cancer Study V.

Chapter 12 Neoadjuvant Chemotherapy in the Conservative Management of Breast Cancers: Study of 143 Patients

Chapter 13 Preliminary results of preoperative chemotherapy with a combination of platinum-bleomycin administered in 5-day cycles in carcinoma of the bronchus.

Chapter 14 Impact of Primary Site of Stage III and IV Squamous Cell Carcinomas of the Head and Neck on 7-Year Survival Figures Following Initial Non-Cisplatin-Containing Combination Chemotherapy

Chapter 15 Chemotherapy with or Without Anticoagulation as Initial Management of Patients with Operable Colorectal Cancer: A Prospective Study with at Least 5 Years Follow-up

Chapter 16 Preoperative Chemotherapy for Gastric Cancer: A Prospective Study with at Least 1 Year Follow-up

Chapter 17 Neoadjuvant Chemotherapy for Osteogenic Sarcoma: A Model for the Treatment of Other Highly Malignant Neoplasms

Chapter 18 Summary of Preoperative (Neoadjuvant) Chemotherapy